Related Experiment Video
Updated: Apr 15, 2026

Methodology for the Study of Horizontal Gene Transfer in Staphylococcus aureus
Published on: March 10, 2017
Improving transformation of Staphylococcus aureus belonging to the CC1, CC5 and CC8 clonal complexes
Mary Janice Jones1, Niles P Donegan1, Irina V Mikheyeva2
1Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States of America.
Abstract:
Methicillin resistant Staphylococcus aureus (MRSA) is an opportunistic pathogen found in hospital and community environments that can cause serious infections. A major barrier to genetic manipulations of clinical isolates has been the considerable difficulty in transforming these strains with foreign plasmids, such as those from E. coli, in part due to the type I and IV Restriction Modification (R-M) barriers. Here we combine a Plasmid Artificial Modification (PAM) system with DC10B E. coli cells (dcm mutants) to bypass the barriers of both type I and IV R-M of S. aureus, thus allowing E. coli plasmid DNA to be transformed directly into clinical MRSA strains MW2, N315 and LAC, representing three of the most common clonal complexes. Successful transformation of clinical S. aureus isolates with E. coli-derived plasmids should greatly increase the ability to genetically modify relevant S. aureus strains and advance our understanding of S. aureus pathogenesis.
Insights
Researchers developed a new method to genetically modify Methicillin-resistant Staphylococcus aureus (MRSA) strains. This technique overcomes restriction-modification barriers, enabling direct transformation of clinical MRSA with E. coli plasmids for better pathogenesis studies.
Area of Science:
- Microbiology
- Molecular Biology
- Genetics
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) is a significant opportunistic pathogen causing severe infections in both hospital and community settings.
- Genetic manipulation of clinical MRSA strains is hindered by type I and IV Restriction Modification (R-M) barriers, complicating the introduction of foreign plasmids like those from E. coli.
Purpose of the Study:
- To develop a method for overcoming R-M barriers in clinical MRSA strains.
- To enable direct transformation of common clinical MRSA isolates with E. coli-derived plasmids.
- To facilitate genetic studies of MRSA pathogenesis.
Main Methods:
- Combined a Plasmid Artificial Modification (PAM) system with DC10B E. coli cells (dcm mutants).
- Utilized this system to bypass type I and IV R-M barriers in Staphylococcus aureus.
- Tested transformation efficiency in clinical MRSA strains MW2, N315, and LAC.
Main Results:
- Successfully bypassed type I and IV R-M barriers in Staphylococcus aureus.
- Enabled direct transformation of clinical MRSA strains (MW2, N315, LAC) with E. coli plasmids.
- Demonstrated a viable method for genetic manipulation of key MRSA clonal complexes.
Conclusions:
- The PAM system combined with DC10B E. coli cells effectively overcomes R-M barriers in MRSA.
- This approach significantly enhances the ability to genetically modify clinically relevant MRSA strains.
- The findings will advance research into MRSA pathogenesis and the development of new therapeutic strategies.
More Related Videos
09:03Multiplex PCR Assay for Typing of Staphylococcal Cassette Chromosome Mec Types I to V in Methicillin-resistant Staphylococcus aureus
Published on: September 5, 2013
08:03Heuristic Mining of Hierarchical Genotypes and Accessory Genome Loci in Bacterial Populations
Published on: December 7, 2021
Related Concept Videos
Staphylococcal Skin Infections
Clinical Significance of Antibiotic Resistance
Bacterial Transformation
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Bacterial Transformation
Transformation
Conjugation